REQUEST A DEMO
Total
USD $0.00
Search more companies

Horster Biotek Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Horster Biotek Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Horster Biotek Private Limited is a manufacturer and supplier of pharmaceutical powders, including hormones, steroids, and other bulk drugs. The company operates an FDA approved facility and serves the pharmaceutical industry worldwide. They offer a wide range of powders, such as Liothronine, Sildenafil Citrate, Clenbuterol, and Testosterone Enanthate. Horster Biotek ensures on-time and secure delivery of their products.

Legal Address
Khasra No. 259, Plot No. 1 & 2 Village Sukhliya, Sanwer Road Industrial Area
Indore; Madhya Pradesh; Postal Code: 452015

Contact Details: Purchase the Horster Biotek Private Limited report to view the information.

Website: http://www.horsterbiotek.com

Basic Information
Outstanding Shares:
Purchase the Horster Biotek Private Limited report to view the information.
Registered Capital:
Purchase the Horster Biotek Private Limited report to view the information.
Incorporation Date:
December 08, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Additional Executive Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Horster Biotek Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-36.84%
Total operating revenue
-36.87%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-17.52%
Total equity
-103.74%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
333.76%
Quick Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?